FDA Regulation of Health IT Systems Testimony

Attached is a pdf of the testimony of FDA’s Director of CDRH Jeff Shuren regarding Health Information Technology Policy. It discusses the need for active regulation FDA regulation, the possible approaches to regulation, and the regulatory basis for this. The Appendix provides some examples of adverse events associated with such systems. It identifies four categories:

1) Errors of commission, such as mixing up patient information
2) Errors of omission or transmission, such as loss or corruption of vital patient data
3) Errors in data analysis, including medication dosing errors
4) Incompatibility between systems which can lead to any of the above.

HIT Policy Committee Meeting Jeff Shuren Testimony

Cybersecurity Review

Our cybersecurity experts are NESSUS Pro Licensed and can quickly remediate cybersecurity deficiencies with your medical device or digital health software.  Planning, requirements, validation, and submissions – we can assist with all.

Interested in having a conversation?  Email us to arrange a Zoom meeting or call us at +1 781-721-2921.


Corporate Office

15148 Springview St
Tampa, FL 33624
Partners located in the US (CA, FL, MA, MN), Canada, and Italy.